로딩 중…
지수 로딩 중…
ARS Pharmaceuticals, Inc.
SPRY· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$9.65-2.53%
2026-06-18
Price Chart
ARS Pharmaceuticals, Inc.-39.35%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $958M |
| Revenue | $99M |
| Net Income | $-198M |
| Total Assets | $288M |
| Net Assets | $61M |
| Value | |
| P/B | 15.63x |
| P/S | 9.68x |
| FCF Yield | -18.30% |
| Profitability | |
| ROA | -68.84% |
| Op. Margin | -204.49% |
| Revenue Growth | 184.47% |
| Earnings Growth | -2241.76% |
| Financial Health | |
| Debt Ratio | 369.06% |
| Total Debt | $97M |
| FCF | $-175M |
| Cash | $24M |
| Current Ratio | 4.94x |
| Performance | |
| 1Y Return | -39.35% |
| 1M Return | 34.59% |
| From 52W High | -48.94% |
| 1Y MDD | -63.32% |
| Trading | |
| Volume | 1,839,163 shares |
| Trading Value | $18M |
| Per Share | |
| EPS | $-1.74 |
| BPS | $1.16 |